Topical Collection on Myeloproliferative Disorders

ISSN: 1558-8211 (Print) 1558-822X (Online)

In this topical collection (10 articles)

  1. Myeloproliferative Disorders (C Harrison, Section Editor)

    Transient Abnormal Myelopoiesis and AML in Down Syndrome: an Update

    Neha Bhatnagar, Laure Nizery, Oliver Tunstall… Pages 333-341
    Download PDF (553KB) View Article

  2. No Access

    Myeloproliferative Disorders (C Harrison, Section Editor)

    Oncogenic Drivers in Myeloproliferative Neoplasms: From JAK2 to Calreticulin Mutations

    Xavier Cahu, Stefan N. Constantinescu Pages 335-343

  3. No Access

    Myeloproliferative Disorders (C Harrison, Section Editor)

    Investigation and Management of Erythrocytosis

    Mary Frances McMullin Pages 342-347

  4. No Access

    Myeloproliferative Disorders (C Harrison, Section Editor)

    Current Challenges in Stem Cell Transplantation in Myelofibrosis

    Nicolaus Kröger Pages 344-350

  5. Myeloproliferative Disorders (C Harrison, Section Editor)

    The Use of Anagrelide in Myeloproliferative Neoplasms, with Focus on Essential Thrombocythemia

    Gunnar Birgegård Pages 348-355
    Download PDF (320KB) View Article

  6. No Access

    Myeloproliferative Disorders (C Harrison, Section Editor)

    Tyrosine Kinase Inhibitors and Therapeutic Antibodies in Advanced Eosinophilic Disorders and Systemic Mastocytosis

    Jason Gotlib Pages 351-361

  7. No Access

    Myeloproliferative Disorders (C Harrison, Section Editor)

    How We Identify and Manage Patients with Inadequately Controlled Polycythemia Vera

    Andreas Reiter, Claire Harrison Pages 356-367

  8. No Access

    Myeloproliferative Disorders (C Harrison, Section Editor)

    Setting Appropriate Goals for the Next Generation of Clinical Trials in Myelofibrosis

    Giovanni Barosi Pages 362-369

  9. No Access

    Myeloproliferative Disorders (C Harrison, Section Editor)

    Immunological Consequences of JAK Inhibition: Friend or Foe?

    Donal P. McLornan, Alesia A. Khan… Pages 370-379

  10. No Access

    Myeloproliferative Disorders (C Harrison, Section Editor)

    What Do Molecular Tests Add to Prognostic Stratification in MF: Is It Time to Add These to Our Clinical Practice?

    Paola Guglielmelli, Giada Rotunno… Pages 380-387